Covid-19:米ギリアド・remdesivir、有効性示さず:WHOの治験結果(動画):  Massive WHO remdesivir study suggests no Covid-19 benefit:  大规模的WHO remdesivir研究表明Covid-19无益处

flu, FDA, Pharmaceutical

COVID-19:EU、レムデシビルの供給契約:見直し必要か(動画):  COVID-19: EU, Remdesivir supply contract: need to be reviewed?:  COVID-19:欧盟,伦贝西比供应合同:需要审核吗?

flu, FDA, Pharmaceutical

COVID-19:iPS細胞を活用:藤田医科大とRebirthel(動画):  COVID-19: Utilizing iPS cells: Fujita Med Univ and Rebirthel:  COVID-19:利用iPS细胞:藤田医科大学和Rebirthel

flu, Medical science, Pharmaceutical

COVID-19:武田薬品、免疫グロブリンの治験開始:18カ国500人参加(動画):  COVID-19: Takeda immunoglobulin trial started: 500 from 18 countries:  COVID-19:武田制药免疫球蛋白试验开始:来自18个国家的500名参与者

flu, Pharmaceutical

COVID-19:中外製薬のアクテムラ:ロシュ、世界で3P開始(動画):  COVID-19: Chugai’s Actemra: Roche, 3P start in the world:  COVID-19:Chugai Pharmaceutical的Actemra:Roche,3P进入全球

flu, Pharmaceutical

Posts navigation